This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Paratek Pharmaceuticals バランスシートの健全性
財務の健全性 基準チェック /16
Paratek Pharmaceuticals has a total shareholder equity of $-201.4M and total debt of $258.3M, which brings its debt-to-equity ratio to -128.3%. Its total assets and total liabilities are $145.8M and $347.2M respectively.
主要情報
-128.3%
負債資本比率
US$258.33m
負債